Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

BACKGROUND: We assessed the effectiveness of cetuximab plus chronomodulated irinotecan, 5-fluorouracil (5-FU), leucovorin (FA) and oxaliplatin (L-OHP) (chrono-IFLO) administered as neoadjuvant chemotherapy to increase the resectability of colorectal liver metastases. METHODS: This was a phase II pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Garufi, C, Torsello, A, Tumolo, S, Ettorre, G M, Zeuli, M, Campanella, C, Vennarecci, G, Mottolese, M, Sperduti, I, Cognetti, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990583/
https://www.ncbi.nlm.nih.gov/pubmed/20959822
http://dx.doi.org/10.1038/sj.bjc.6605940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990583/
https://www.ncbi.nlm.nih.gov/pubmed/20959822
http://dx.doi.org/10.1038/sj.bjc.6605940

Ejemplares similares